[1]
|
Brenneisen, R. (2007) Marijuana and the Cannabinoids: Chemistry and Analysis of Phytocannabinoids and Other Cannabis Constitu-ents. Humana Press, Totowa, 17-49. https://doi.org/10.1007/978-1-59259-947-9_2
|
[2]
|
Adams, R., Hunt, M. and Clark, J.H. (1940) Structure of Cannabidiol, a Product Isolated from the Marihuana Extract of Minnesota Wild Hemp. Journal of the American Chemical Society, 62, 196-200.
https://doi.org/10.1021/ja01858a058
|
[3]
|
Schier, A.R., Ribeiro, N.P., Silva, A.C., et al. (2012) Cannabidiol, a Cannabis sativa Constituent, as an Anxiolytic Drug. The Revista Brasileira de Psiquiatria, 34, 104-117. https://doi.org/10.1016/S1516-4446(12)70057-0
|
[4]
|
Devinsky, O., Cilio, M.R., Cross, H., et al. (2014) Cannabidiol: Pharma-cology and Potential Therapeutic Role in Epilepsy and Other Neuropsychiatric Disorders. Epilepsia, 55, 791-802. https://doi.org/10.1111/epi.12631
|
[5]
|
Rong, C., Lee, Y., Carmona, N.E., et al. (2017) Cannabidiol in Medical Marijuana: Re-search Vistas and Potential Opportunities. Pharmacological Research, 121, 213-218. https://doi.org/10.1016/j.phrs.2017.05.005
|
[6]
|
Blessing, E.M., Steenkamp, M.M., Manzanares, J., et al. (2015) Cannabidiol as a Potential Treatment for Anxiety Disorders. Neurotherapeutics, 12, 825-836. https://doi.org/10.1007/s13311-015-0387-1
|
[7]
|
McGuire, P., Robson, P., Cubala, W.J., et al. (2017) Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial. American Journal of Psychiatry, 175, 225-231.
https://doi.org/10.1176/appi.ajp.2017.17030325
|
[8]
|
Zuardi, A.W., Morais, S.L., Guimarães, F.S., et al. (1995) Antipsychotic Effect of Cannabidiol. Journal of Clinical Psychiatry, 56, 485-486.
|
[9]
|
Grimm, O., Löffler, M., Kamping, S., et al. (2018) Probing the Endocannabinoid System in Healthy Volunteers: Cannabidiol Alters Fronto-Striatal Resting-State Connectivity. European Neuro-psychopharmacology, 28, 841-849.
https://doi.org/10.1016/j.euroneuro.2018.04.004
|
[10]
|
Morgan, C.J.A., Freeman, T.P., Hindocha, C., et al. (2018) Individual and Combined Effects of Acutedelta-9-Te- trahydrocannabinol and Cannabidiol on Psychotomimetic Symptoms and Memory Function. Translational Psychiatry, 8, 181-190. https://doi.org/10.1038/s41398-018-0191-x
|
[11]
|
Trigo, J.M., Soliman, A., Quilty, L.C., et al. (2018) Nabiximols Combined with Motivational Enhancement/Cognitive Behavioral Therapy for the Treatment of Cannabis De-pendence: A Pilot Randomized Clinical Trial. PLoS ONE, 13, e0190768. https://doi.org/10.1371/journal.pone.0190768
|
[12]
|
Hindocha, C., Freeman, T., Grabski, M., et al. (2018) Cannabidiol Reverses Attentional Bias to Cigarette Cues in a Human Experimental Model of Tobacco Withdrawal. Addiction, 113, 1696-1705. https://doi.org/10.1111/add.14243
|
[13]
|
Silva, V.K., Freitas, B.S., Garcia, R.C.L., et al. (2018) Antiapoptotic Effects of Canna-bidiol in an Experimental Model of Cognitive Decline Induced by Brain Iron Overload. Translational Psychiatry, 8, 176-183.
https://doi.org/10.1038/s41398-018-0232-5
|
[14]
|
Cheng, D., Low, J.K., Logge, W., et al. (2014) Chronic Cannabidiol Treatment Improves Social and Object Recognition in Double Transgenic APPswe/PS1ΔE9 Mice. Psychopharmacology, 231, 3009-3017.
https://doi.org/10.1007/s00213-014-3478-5
|
[15]
|
Sagredo, O., Palazuelos, J., Gutierrez-Rodriguez, A., et al. (2018) Cannabinoid Signalling in the Immature Brain: Encephalopathies and Neurodevelopmental Disorders. Biochemical Pharmacology, 157, 85-96.
https://doi.org/10.1016/j.bcp.2018.08.014
|
[16]
|
Lozano, I. (2001) The Therapeutic Use of Cannabis sativa (L.) in Arabic Medicine. Journal of Cannabis Therapeutics, 1, 63-70. https://doi.org/10.1300/J175v01n01_05
|
[17]
|
O’Shaughnessy, W.B. (1943) On the Preparations of the Indian Hemp, or Gunjah: Cannabis Indica Their Effects on the Animal System in Health, and their Utility in the Treatment of Tetanus and other Convulsive Diseases. Provincial Medical Journal and Retrospect of the Medical Sciences, 5, 363-369.
|
[18]
|
Hussain, S.A., Raymond, Z., Jacobson, C., et al. (2015) Epilepsy & Behavior Perceived Efficacy of Cannabidi-ol-Enriched Cannabis Extracts for Treatment of Pediatric Epilepsy : A Potential Role for Infantile Spasms and Lennox-Gastaut Syn-drome. Epilepsy & Behavior, 47, 138-141. https://doi.org/10.1016/j.yebeh.2015.04.009
|
[19]
|
Tzadok, M., Uliel-Siboni, S., Linder, I., et al. (2016) CBD-Enriched Medical Cannabis for Intractable Pediatric Epilepsy The Current Israeli Experience. Seizure, 35, 41-44. https://doi.org/10.1016/j.seizure.2016.01.004
|
[20]
|
Kaplan, J.S., Stella, N., Catterall, W.A., et al. (2017) Cannabidiol Attenuates Seizures and Social Deficits in a Mouse Model of Dravet Syndrome. Proceedings of the National Academy of Sciences, 114, 11229-11234.
https://doi.org/10.1073/pnas.1711351114
|
[21]
|
McCoy, B., Wang, L., Zak, M., et al. (2017) A Prospective Open-Label Trial of a CBD/THC Cannabis Oil in Dravet Syndrome. Annals of Clinical and Translational Neurology, 5, 1077-1088. https://doi.org/10.1002/acn3.621
|
[22]
|
Devinsky, O., Cross, H., Nabbout, R., et al. (2017) Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. The New England Journal of Medicine, 376, 2011-2020. https://doi.org/10.1056/NEJMoa1611618
|
[23]
|
Kaplan, B.A., Offermann, B.A., Sievers, M.A., et al. (2017) Cannabidiol Treat-ment for Refractory Seizures in Sturge-Weber Syndrome. Pediatric Neurology, 71, 18-23. https://doi.org/10.1016/j.pediatrneurol.2017.02.009
|
[24]
|
Lattanzi, S., Brigo, F., Cagnetti, C., et al. (2018) Efficacy and Safety of Adjunctive Cannabidiol in Patients with Lennox-Gastaut Syndrome: A Systematic Review and Meta‑Analysis. CNS Drugs, 32, 905-916.
https://doi.org/10.1007/s40263-018-0558-9
|
[25]
|
Office of the Commissioner (2018) FDA Approves First Drug Comprised of an Active Ingredient Derived from Marijuana to Treat Rare, Severe Forms of Epilepsy.
|
[26]
|
Rajan, T.S., Giacoppo, S., Iori, R., et al. (2016) Anti-Inflammatory and Antioxidant Effects of a Combination of Cannabidiol and Moringin in LPS-Stimulated Macrophages. Fitoterapia, 112, 104-115.
https://doi.org/10.1016/j.fitote.2016.05.008
|
[27]
|
Ribeiro, A., Paula, V.F., Pinheiro, M.L., et al. (2012) Cannabidiol, a Non-Psychotropic Plant-Derived Canna Binoid, Decreases Inflammation in a Murine Model of Acute Lung Injury: Role for the Adeno-sine A2A Receptor. European Journal of Pharmacology, 678, 78-85. https://doi.org/10.1016/j.ejphar.2011.12.043
|
[28]
|
Burstein, S. (2015) Cannabidiol (CBD) and Its Analogs: A Review of Their Effects on Inflammation. Bioorganic & Medicinal Chemistry, 23, 1377-1385. https://doi.org/10.1016/j.bmc.2015.01.059
|
[29]
|
Javid, F.A., Phillips, R.M., Afshinjavid, S., et al. (2016) Cannabinoid Pharmacology in Cancer Research: A New Hope for Cancer Patients? European Journal of Pharmacology, 775, 1-14. https://doi.org/10.1016/j.ejphar.2016.02.010
|
[30]
|
Elbaz, M., Nasser, M.W., Ravi, J., et al. (2015) Modulation of the Tumor Mi-croenvironment and Inhibition of EGF/EGFR Pathway: Novel Anti-Tumor Mechanisms of Cannabidiol in Breast Cancer. Molecular Oncology, 9, 906-919.
https://doi.org/10.1016/j.molonc.2014.12.010
|
[31]
|
Sultan, A.S., Marie, M.A. and Sheweita, S.A. (2018) Novel Mechanism of Cannabidiol-Induced Apoptosis in Breast Cancer Cell Lines. The Breast, 41, 34-41. https://doi.org/10.1016/j.breast.2018.06.009
|
[32]
|
Scott, K.A., Dalgleish, A.G. and Liu, W.M. (2014) The Combination of Canna-bidiol and Δ9-Tetrahydrocannabinol Enhances the Anticancer Effects of Radiation in an Orthotopic Murine Glioma. Molecular Cancer Therapeutics, 13, 2955-2967. https://doi.org/10.1158/1535-7163.MCT-14-0402
|
[33]
|
Solinas, M., Massi, P., Cinquina, V., et al. (2013) Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect. PLoS ONE, 8, e76918.
https://doi.org/10.1371/journal.pone.0076918
|
[34]
|
Lukhele, S.T. and Motadi, L.R. (2016) Cannabidiol Rather than Cannabis sativa Extracts Inhibit Cell Growth and Induce Apoptosis in Cervical Cancer Cells. BMC Complementary and Alternative Medicine, 16, 335-350.
https://doi.org/10.1186/s12906-016-1280-0
|
[35]
|
Haustein, M., Ramer, R., Linnebacher, M., et al. (2014) Cannabinoids Increase Lung Cancer Cell Lysis by Lym Phokine-Activated Killer Cells via Upregulation of Icam-1. Biochemical Pharmacology, 92, 312-325.
https://doi.org/10.1016/j.bcp.2014.07.014
|
[36]
|
Fernández, ó. (2016) THC: CBD in Daily Practice: Available Data from UK, Germany and Spain. European Neurology, 75, 1-3. https://doi.org/10.1159/000444234
|
[37]
|
陈轶翔. 美国拟放宽医用大麻种植基地[J]. 世界科学, 2015(10): 10-11.
|
[38]
|
Markovà, J., Essner, U., Akmaz, B., et al. (2018) Sativex® as Add-On Therapy vs. Fur-ther Optimized First-Line ANTispastics (SAVANT) in Resistant Multiple Sclerosis Spasticity: A Double-Blind, Placebo-Controlled Randomised Clinical Trial. International Journal of Neuroscience, 129, 1-10.
|
[39]
|
Horváth, B., Mukhopadhyay, P., Haskó, G., et al. (2012) The Endocannabinoid System and Plant-Derived Cannabinoids in Diabetes and Diabetic Complications. The American Journal of Pathology, 180, 432-442.
https://doi.org/10.1016/j.ajpath.2011.11.003
|
[40]
|
Matouk, A.I., Taye, A., Mohamed, A., et al. (2018) Abnormal Cannabidiol Confers Cardioprotection in Diabetic Rats Independent of Glycemic Control. European Journal of Pharmacology, 820, 256-264.
https://doi.org/10.1016/j.ejphar.2017.12.039
|
[41]
|
Morais, H., Chaves, Y.C., Waltrick, A.P.F., et al. (2018) Sub-Chronic Treat-ment with Cannabidiol But Not with URB597 Induced a Mild Antidepressant-Like Effect in Diabetic Rats. Neuroscience Letters, 682, 62-68.
https://doi.org/10.1016/j.neulet.2018.06.006
|
[42]
|
Massi, P., Solinas, M., Cinquina, V., et al. (2013) Cannabidiol as Potential An-ticancer Drug. British Journal of Clinical Pharmacology, 75, 303-312. https://doi.org/10.1111/j.1365-2125.2012.04298.x
|
[43]
|
Cuñetti, L., Manzo, L., Peyraube, R., et al. (2018) Chronic Pain Treatment with Cannabidiol in Kidney Transplant Patients in Uruguay. Transplantation Proceedings, 50, 461-464. https://doi.org/10.1016/j.transproceed.2017.12.042
|
[44]
|
Hunter, D., Oldfield, G., Tich, N., et al. (2018) Synthetic Transdermal Cannabidiol for the Treatment of Knee Pain Due to Osteoarthritis. Osteoarthritis and Cartilage, 26, 26. https://doi.org/10.1016/j.joca.2018.02.067
|
[45]
|
Silvestri, C., Paris, D., Martella, A., et al. (2015) Two Non-Psychoactive Canna-binoids Reduce Intracellular Lipid Levels and Inhibit Hepatosteatosis. Journal of Hepatology, 62, 1382-1390. https://doi.org/10.1016/j.jhep.2015.01.001
|
[46]
|
Yang, L.L., Rozenfeld, R., Wu, D.F., et al. (2014) Cannabidiol Protects Liver from Binge Alcohol-Induced Steatosis by Mechanisms Including Inhibition of Oxidative Stress and Increase in Autophagy. Free Radi-cal Biology & Medicine, 68, 260-267. https://doi.org/10.1016/j.freeradbiomed.2013.12.026
|
[47]
|
张业亮. 大麻合法化何以在美国蔓延[J]. 世界知识, 2015(3): 35-37.
|